TypeDrawer/FileDate ModifiedSize

pdf
1st Line Emollients Reviewed 2021 13:02 08/24/2021218.1k

pdf
22 CS Upadacitinib for AS 15:30 12/21/2022150.5k

pdf
2022 CS (NICE TA274) Ranibizumab Diabetic Macular Oedema 12:30 12/23/2022139.9k

pdf
2022 CS Ciclosporin in Dry Eye 15:21 12/22/202294.7k

pdf
2023 Oct Bulletin METHYLPHENIDATE & Other ADHD Meds Shortage V3 11:54 11/01/2023268.9k

pdf
2024 CS Fluocinolone Chronic Diabetic Macular Oedema 12:13 04/09/2024134.3k

pdf
07648 Vaccine Ordering for 2018-19 Influenza Season GPpharm 05022018 Doc 09:11 07/10/2018333.8k

pdf
Acamprosate SCG V2 1 Final Version 15:05 08/21/2023381.4k

pdf
Accessing Medicines for Adults at End of Life in the Community July 2023 12:25 08/01/2023192.1k

pdf
Acne Vulgaris Pathway 2018 09:53 02/27/2019658.8k

pdf
Actinic Keratosis Pathway Primary Care Nov 2022 15:52 12/21/2022435.8k

pdf
Adult Asthma Guideline 2022 Dorset Version 12 May 23 13:41 08/23/2023354.6k

pdf
Anti Microbial Product Information for the Treatment of Infected Critically Colonised Wounds Updated 2024 12:59 03/14/2024113.4k

pdf
Anticipatory Prescribing at the End of Life in the Community July 23 12:26 08/01/2023229.7k

jpg
Antimicrobial SB Sticker 10:31 11/16/201882.3k

pdf
Antipsychotic Monitoring and Reviews MOG 22 10:01 08/18/2022277.3k

pdf
Aripiprazole for Bipolar I in Adolescents 09:10 07/10/2018267.1k

pdf
Avatrombopag Commissioning Statement NICE TA 626 V1 15:36 07/30/2020121.6k

pdf
BASH Patient Information Sheet Verapamil for Cluster Headache 15:47 05/02/2023265.1k

pdf
BPSD Guidance Final V2 Oct 2021 13:52 04/11/2023403.3k

pdf
Benzodiazepines Support Pack Aug16 09:10 07/10/2018655.3k

pdf
Biologics Decision Aid for Psoriasis 1 Updated August 2020 09:22 09/08/2020207.8k

pdf
Biologics Decision Aid for Psoriasis 2 Updated August 2020 14:54 09/07/2020171.5k

pdf
Biologics Pathway for Axial Spondyloarthritis Oct 23 13:04 12/20/202366.4k

pdf
Botulinum Toxin Type A 15:15 09/16/2022496.9k

pdf
Botulinum Toxin Type A for Overactive Bladder 15:15 09/16/2022493.2k

pdf
Bowel Management Pathway March 24 17:09 03/07/2024162.1k

pdf
CEM CMO 2023-003 17:39 12/14/2023205.4k

pdf
COMMISSIONING STATEMENT FOR PRESCRIBING RIFAXIMIN (TARGAXAN®) 12:04 10/12/2020189.8k

pdf
COMMISSIONING STATEMENT ON THE USE OF PRUCALOPRIDE 12:04 10/12/2020146.6k

pdf
COMMISSIONING STATEMENT Pcsk9 09:11 07/10/2018408.9k

docx
COVID19 Support in the Last Weeks of Life V1 4 (002) 16:25 03/27/202024.7k

pdf
CS49930 Eczema Clinical Pathway 1 10:13 12/27/2023232.1k

pdf
CS Andexanet March 23 16:20 05/02/2023156.9k

pdf
CS Bempedoic Acid with Ezetimbe NICE TA694 15:45 04/28/2023147.4k

pdf
CS Dapagliflozin NICE TA902 July 23 14:42 08/30/2023134k

pdf
CS Ivabradine NICE TA267 15:45 04/28/2023140.7k

pdf
CS TA744 Upadacitinib in Moderate RA 10:27 12/17/2021150.3k

pdf
CS Ticagrelor NICE TA 420 & 236 15:45 04/28/2023223.6k

pdf
CS Tirzepatide for Treating Type 2 Diabetes NICE TA924 (002) 15:24 04/17/2024196.3k

pdf
CS Vedolizumab for Active Crohns Disease NICE TA352 16:09 05/02/2023206.2k

pdf
CS Vedolizumab for Active Ulcerative Colitis NICE TA342 16:05 05/02/2023147.3k

pdf
CS Budesonide for Eosinophilic Oesophagitis NICE TA708 16:14 05/02/2023144.2k

pdf
CS Dapagliflozin for Heart Failure NICE TA679 Updated July 23 14:42 08/30/2023144.4k

pdf
CS Erythropoiesis Stimulating Agents for TA 323 Jan 15 09:11 07/10/2018216.8k

pdf
CS for Tofacitinib in UC NICE TA547 (1) 15:44 05/02/2023158.4k

pdf
CS for Vedolizumab in UC 09:11 07/10/2018403.4k

pdf
CS Lurasidone August 2014 09:11 07/10/2018220.9k

pdf
CS Rivaroxaban in CAD or PAD NICE TA607 15:53 04/28/2023115.9k

pdf
Calcipotriol & Betamethasone Presc Guideline Nov 2023 12:59 12/20/2023143.6k

pdf
Cannabis Oil Containing Products (unlicensed) Guidance March 21 15:18 05/10/2021105.5k

pdf
Cardiology Amiodarone A4 Leaflet June 2020 12:45 05/19/202194.9k

pdf
Cardiology COMMISSIONING STATEMENT Rivaroxaban in ACS (1) 12:48 09/16/2022177.5k

pdf
Cardiology Commissioning Statement Inclisiran 14:55 12/17/2021272.1k

pdf
Cardiology Commissioning Statement TA 599 Sodium Zirconium Cyclosilicate (1) 13:31 05/06/2022267.1k

pdf
Cardiology Working Group Statement on Metolazone Oct 21 14:55 12/17/2021121.6k

pdf
Cenobamate for Focal Onset Seizures TA753 Commissioning Statement 15:53 05/09/2022159.9k

pdf
Cerazette Guidance on Its Use OCT 09 09:11 07/10/201844.1k

pdf
Ciclosporin Eye Drops Information Leaflet 14:40 12/21/2022221.1k

pdf
Clobetasol Neomycin Nystatin Guideline 2023 12:52 12/20/2023119.9k

docx
Clozapine SCR Letter CMHT 09:56 01/20/202040.9k

pdf
Commisioning Statement for TNF A Inhibitors for Ankylosing Spondylitis and Axial Spondyloarthritis July 2021 11:12 08/24/2021174.9k

pdf
Commissioning Statement Bimekizumab for Treating Active Psoriatic Arthritis NICE TA916 12:45 12/20/2023149.5k

pdf
Commissioning Statement Biological DMARDs in Moderate RA NICE TA715 V3 17:01 07/26/2023195.2k

pdf
Commissioning Statement Empagliflozin NICE TA929 Nov 23 12:37 12/20/2023116.3k

pdf
Commissioning Statement Filgotinib NICE TA676 April 23 16:45 07/26/2023121.9k

pdf
Commissioning Statement Filgotinib for Ulcerative Colitis Jan 24 14:15 02/26/2024182.1k

pdf
Commissioning Statement Ixekizumab TA537 April 2023 14:45 07/26/2023145.1k

pdf
Commissioning Statement July 2021 Certoliz and Secukiumab for PSA 11:04 08/24/2021191.6k

pdf
Commissioning Statement Lusutrombopag 13:53 04/30/2020122.7k

pdf
Commissioning Statement N Acetylcysteine Jan 15 09:11 07/10/2018213.2k

pdf
Commissioning Statement Ozanimod for Ulcerative Colitis 15:36 12/21/2022156.2k

pdf
Commissioning Statement Pentosan 11:22 02/03/2020434.3k

pdf
Commissioning Statement Rimegepant For Preventing Migraine NICE TA906 14:22 10/04/2023100.4k

pdf
Commissioning Statement Romosozumab 10:01 08/18/2022181k

pdf
Commissioning Statement TA718 Ixekizumab for Axial Spondyloarthritis 14:32 10/12/2021145.5k

pdf
Commissioning Statement TA719 Secukinumab for Axial Spondyloarthritis 14:32 10/12/2021147.7k

pdf
Commissioning Statement Ticagrelor July 2021 15:18 08/20/2021222.6k

pdf
Commissioning Statement Vedolizumab for Active Crohns Disease March 2021 21:48 04/26/2021163.6k

pdf
Commissioning Statement Vedolizumab for Active Ulcerative Colitis March 21 21:48 04/26/2021161.8k

pdf
Commissioning Statement XEOMIN (BOTULINUM NEUROTOXIN TYPE A 15:45 12/18/2019141.9k

pdf
Commissioning Statement for Apremilast for PSA July 2021 11:21 08/24/2021178.4k

pdf
Commissioning Statement for Baricitinib NICE TA466 April 23 16:56 07/26/2023173.7k

pdf
Commissioning Statement for Brodalumab Reviewed 2021 12:11 08/24/2021169.4k

pdf
Commissioning Statement for Daridorexant 11:28 01/16/2024153.1k

pdf
Commissioning Statement for Empagliflozin NICE TA733 Nov 23 12:39 11/24/2023168.4k

pdf
Commissioning Statement for Mirikizumab for Treating Moderately to Severely Active Ulcerative Colitis Oct 23 12:02 12/20/2023133.8k

pdf
Commissioning Statement for NICE TA345 Naloxegol and TA651 Naldemedine 12:30 02/17/2023204.1k

pdf
Commissioning Statement for PRUCALOPRIDE NICE TA211 (1) 12:30 02/17/2023149.9k

pdf
Commissioning Statement for Rimegepant for Treating Migraine 11:32 01/16/2024151.2k

pdf
Commissioning Statement for TA375 DMARDs RA July 2021 11:34 08/24/2021148.9k

pdf
Commissioning Statement for TA375 RA April 23 14:27 08/31/2023129.3k

pdf
Commissioning Statement for Tofacitinib for Treating Active Ankylosing Spondylitis Oct 23 12:18 12/20/2023125.1k

pdf
Commissioning Statement for Upadacitinib for Non Radiographic AS 15:18 04/28/2023151.5k

pdf
Commissioning Statement for Ustekinumab for Crohns NICE TA456 12:30 02/17/2023165.7k

pdf
Commissioning Statement for Ustekinumab for UC NICE TA633 12:30 02/17/2023236.4k

pdf
Commissioning Statement for Eulaxadoline 09:11 07/10/2018489.1k

pdf
Commissioning Statement for Golimumab NICE TA497 April 23 16:08 07/26/2023165.8k

pdf
Commissioning Statement for Tofacitinib TA543 April 23 14:53 07/26/2023120.5k

pdf
Commissioning Statement for Upadacitinib NICE TA665 April 23 16:26 07/26/2023139.8k

pdf
Commissioning Statement for Ustekinumab Crohns 12:04 10/12/2020209.4k

pdf
Commissioning Statement for Ustekinumab Crohns Sep 2017 09:11 07/10/2018613.6k

pdf
Commissioning Statement for Ustekinumab in Active PSA July 2021 10:54 08/24/2021159.1k

pdf
Commissioning Statement for Ustekinumab in Active PSA NICE TA340 April 23 V3 16:49 07/26/2023145.5k

pdf
Commissioning Statement Relugolix Estradiol Norethisterone 16:35 01/10/2023161.4k

pdf
Commissioning Statement Upadacitinib for Ulcerative Colitis Jan 23 (1) 13:00 02/17/2023342.7k

pdf
Commissioning Statement Glp 1s 09:11 07/10/2018222.5k

pdf
Commissioning Statement Cannabis Updated Dec 20 13:00 02/09/2021210.2k

pdf
Commissioning Statement Erenumab Reviewed Feb 2023 10:59 05/31/2023126k

pdf
Commissioning Statement Finerenone May 23 Final 14:23 07/26/2023186.5k

pdf
Commissioning Statement Fluocinolone IVI 09:58 10/17/2019105.7k

pdf
Commissioning Statement GLP 1s March 2019 13:04 04/05/2019389.7k

pdf
Commissioning Statement Galcanezumab Reviewed Feb 2023 11:14 05/31/2023128k

pdf
Commissioning Statement Liraglutide Saxenda Weight Management Dec 2020 13:00 02/09/2021130.3k

pdf
Commissioning Statement PCSK9 July 2021 15:00 08/20/2021175.5k

pdf
Commissioning Statement TA 599 Sodium Zirconium Cyclosilicate Vs 11:19 10/17/2019171.5k

pdf
Commissioning Statement for Bimekizumab for Treating Axial Spondyloarthritis NICE TA918 12:32 12/20/2023133k

pdf
Commissioning Statement for IQoro Feb 23 14:55 04/28/202391.6k

pdf
Commissioning Statement for Sarilumab July 2021 11:15 08/24/2021138k

pdf
Commissioning Statement for Avatrombopag for Primary ITP Jan 23 12:30 02/17/2023137.8k

pdf
Commissioning Statement for Biosimilar May 2023 12:52 06/30/2023132.7k

pdf
Commissioning Statement for Dexamethasone in Diabetic Macular Oedema 09:11 07/10/2018335.3k

pdf
Commissioning Statement for Infliximab, Adalimumab and Golimumab NICE TA329 (1) 12:30 02/17/2023248.4k

pdf
Commissioning Statement for Liraglutide (Saxenda) 09:36 10/19/2018395.5k

pdf
Commissioning Statement for Secukinumab in Plaque Psoriasis 09:11 07/10/2018216.4k

pdf
Commissioning Statement Ixekizumab Ta537 July 2018 09:36 10/19/2018503.8k

pdf
Commissioning Statement on the Use of Infliximab, Adalimumab and Golimumab 12:04 10/12/2020158.7k

pdf
Commissioning Statement Pigmanorm Updated July 18 09:36 10/19/2018383.1k

pdf
Commissioning Statement Risankizumab 12:53 09/19/2019495k

pdf
Commissioning Statement Risankizumab (1) 09:58 10/17/2019495k

pdf
Commissioning Statement Tildrakizumab Plaque Psoriasis Reviewed June 2021 12:23 08/24/2021129.7k

pdf
Community Pharmacy Palliative Care Drugs List Final 23 11:50 02/28/2024130.2k

pdf
Continence DCHS off Formulary Form 09:11 07/10/201824.3k

pdf
Copy of Dorset Christmas New Year 2022-23 Pack FINAL V2 13:31 12/23/2022205.6k

pdf
Counselling Checklist for DOACs RBH 14:11 02/28/2019133.9k

pdf
Criteria Based Access Protocol Botulinum Toxin Type A 09:11 07/10/2018496.9k

pdf
Cynrize DHPC 270617 09:11 07/10/2018316.3k

pdf
DCCG Labetalol Shortage Final 120419 16:14 04/12/2019341.8k

pdf
DFU SOC Pathway Dorset Leaflet 12:17 08/19/2022191.9k

pdf
DFU SOC Pathway Dorset Leaflet Updated Feb 2024 12:59 03/14/2024289.8k

pdf
DHC BPSD Guidance Final Version 1 1 May 2019 10:53 07/27/2021286k

pdf
DHC Guideline Medication and the Risk of Falls V2 14:01 05/15/2019299.3k

pdf
DHC Guidelines on the Use of Medication for the Managment of Behaviour That Challenges in Dementia V1 Point 1 2019 13:19 07/28/2021286k

pdf
DMAG Annual Report 2022-2023 14:06 07/27/2023439.3k

pdf
DMAG Summary Jan 23 14:29 02/21/2023296.2k

pdf
DMAG Summary July 2023 16:36 08/30/2023183.1k

pdf
DMAG Summary March 2023 15:21 05/03/2023254.7k

pdf
DMAG Summary May 2023 (1) 14:06 07/27/2023242.3k

pdf
DMAG Summary November 23 10:29 12/27/2023223.3k

pdf
DMAG Summary September 2023 10:53 11/02/2023163.6k

pdf
DUAL ANTIPLATELET THERAPY IN ACUTE CORONARY SYNDROME 09:11 07/10/2018275.6k

pdf
Dapagliflozin for CKD Commissioning Statement March 2022 DMAG Final 16:53 06/15/2022165.4k

pdf
Dec 2018 KTTT 12:21 12/28/2018575.7k

pdf
Degarelix Commissioning Statement 09:11 07/10/2018198.7k

pdf
Delaying Menstruation During Holidays 09:11 07/10/2018193.7k

pdf
Deprescribing Bisphosphonates 14:50 12/21/2022234.5k

pdf
Derm 2023 CS Pigmanorm 14:18 03/28/202394.1k

pdf
Dermatology CS Apremilast in Moderate Severe Plaque Psoriasis 16:01 12/22/2022158.1k

pdf
Dermatology CS Baricitinib for Dermatitis April 23 12:01 07/20/2023196.1k

pdf
Dermatology CS Certolizumab TA574 Psoriasis 16:08 12/22/2022122k

pdf
Dermatology CS Dundee Sunscreen 2022 09:54 03/30/2023190.7k

pdf
Dermatology CS Dupilumab Moderate Severe Atopic Dermatitis 15:55 12/22/2022151.8k

pdf
Dermatology CS Ixekizumab Moderate Severe Plaque Psoriasis (2) 16:13 12/22/2022119.5k

pdf
Dermatology CS Omalizumab in Chronic Spontaneous Urticaria 15:34 12/22/2022117.5k

pdf
Dermatology CS Risankizumab Moderate Severe Plaque Psoriasis (1) 15:41 12/22/2022118.8k

pdf
Dermatology CS Secukinumab in Moderate Severe Plaque Psoriasis 15:50 12/22/2022144.3k

pdf
Dermatology CS for Bimekizumab for Plaque Psoriasis April 23 12:58 07/20/2023161.6k

pdf
Dermatology CS Tildrakizumab for Plaque Psoriasis April 23 (1) 12:18 07/20/2023123.4k

pdf
Diabetes Appendix 3 Draft Guidance for Insulin Start in Type 2 Diabetes 14:25 12/14/2020130.2k

pdf
Diabetes Appendix 4 Draft Growth Hormone in Children and Adults Commissioning Statement Vs Edits (002) 14:25 12/14/2020156.6k

pdf
Diabetes CGM FAQs V 2 1 Sept 23 10:44 10/23/2023164.7k

pdf
Diabetes GLP 1s Commissioning Statement Nov 2021 15:09 12/16/2021145.6k

pdf
Diabetes Local Guidance for the Safe Use of SGLT2i (1) 14:47 04/28/2023305.2k

pdf
Diabetes Foot Wound Care Formulary and Anti Microbial Management Updated February 2024 12:59 03/14/2024231.3k

pdf
Diamorphine Primary Care Communication May 2019 12:31 05/24/2019121.3k

pdf
Dilantin Infatab DHCP Letter CCC (Final Version) 11:57 05/07/2019172.7k

PDF
Dilantin PIL 12:19 05/08/2019254.9k

pdf
Dilantin PIL and Monograph 16:47 06/06/2019438.1k

pdf
Direct Oral Anticoagulants 11:51 02/07/2020222.9k

docx
Direct Oral Anticoagulants AB V3 March 19 09:16 03/29/201976.3k

PDF
Discontinuation of 40K Patient Letter 10:41 04/01/2019462.7k

pdf
Dorset Asthma Prescribing Guide for CYP Final V 2 May 23 13:41 08/23/2023376.7k

pdf
Dorset Biologic RA Pathway V2 May 2021 16:06 06/22/2021124.9k

pdf
Dorset Biologics Pathway for Psoriatic Arthritis Oct 23 16:44 12/19/2023103.3k

pdf
Dorset Bowel Continence Formulary 5th Edition Booklet for Printing Mar24 17:09 03/07/20241.1M

pdf
Dorset Bowel Continence Formulary 5th Edition March25 17:09 03/07/20241.1M

pdf
Dorset Bowel Continence Formulary Edition 4 Booklet for Self Printing 2022 12:30 02/17/2023491k

pdf
Dorset Bowel Continence Formulary Edition 4 Final Version 2022 12:30 02/17/2023498.3k

pdf
Dorset CCG Prescribing for Overseas Travel V4 1 April 2021 09:53 09/01/2021238.7k

pdf
Dorset COPD Guideline 2022 V4 Post DMAG Additions (002) 15:54 12/21/2022435k

pdf
Dorset Green Inhaler Guidance DMAG Version V2 (2) 14:52 09/16/20221M

pdf
Dorset Guideline for Replacement of Iron in Iron Deficiency Anaemia 2024 13:56 03/28/2024260.8k

pdf
Dorset Insulin Formulary for Type 1 Type 2 Diabetes in Adults Nov 23 16:13 01/04/2024137.5k

pdf
Dorset Opioid Resource Pack FINAL Sept 2020 08:50 09/17/20201.6M

pdf
Dorset Pathway for Bisphosphonates in Post Menopausal Women 09:11 07/10/2018326.5k

pdf
Dorset Primary and Secondary Management of Osteoporosis Guidance 09:11 07/10/2018438.9k

docx
Dorset Shared Care Guideline TEMPLATE Jan 23 (1) 12:23 03/21/202360.3k

pdf
Dorset Vitamin and Mineral Supplementation Guidelines 2022 16:20 01/27/2023133.6k

pdf
Dorset Vitamin and Mineral Supplementation Guidelines 2024 V2 13:56 03/28/2024189.3k

pdf
Dorset Guidelines for the Use of Digifab 09:11 07/10/2018535.1k

pdf
Dorset Healthcare Medicines Team Leaflet 042019 09:40 04/02/2019477.9k

docx
Dorset Imms Incident Reporting Form FINAL V1 0 11:26 05/12/202056.7k

pdf
Dorset Version SCP Amiodarone for Patients Within Adult Services (2) 11:49 05/17/2023383.3k

pdf
Dorset Version SCP Dronedarone for Patients in Adult Services (3) 11:49 05/17/2023390.2k

pdf
Doxazosin Conversion FINAL2015 10:10 10/05/2018162k

pdf
Dry Eye Prescribing Guidelines 09:09 05/04/2020240.2k

pdf
EMA Recommendation to Restrict Strontium Usage 09:11 07/10/201877.4k

pdf
ENC 57g IN USE EXPIRY OF EYE DROPS IN A SECONDARY CARE SETTING May 2019 Approved 16:29 07/31/2019253.4k

docx
ENC Cv Communication for Care Homes 09:11 07/10/201815k

pdf
ENC D Regulation 28 Letter 15 12 17 07519 09:11 07/10/2018213.5k

pdf
ENC Giii FCP Pathway Final 09:11 07/10/2018284k

pdf
ENC I Accolate Discontinuation Letter Others Sep 17 09:11 07/10/2018107.2k

pdf
EllaOne Guidance March 2010 09:11 07/10/201830k

pdf
Eltrombopag 09:11 07/10/2018281.6k

pdf
Emollient Patient Letter Final 09:21 07/19/2018303.4k

pdf
Emollient Comparison Chart 09:11 07/10/2018558.7k

pdf
Emollient Comparison Chart Final 09:21 07/19/2018385.6k

pdf
Emollient Comparison Chart 2021 12:53 08/24/2021242k

pdf
Empagliflozin for CKD Commissioning Statement March 24 16:40 03/14/2024174.3k

pdf
Enc Oi Urinary Incontinence Product Booklet Oct16GB 2 09:11 07/10/2018641.9k

pdf
Endocrine Cancer DRAFT Standard Regimen List 09:11 07/10/201813.2k

pdf
End of Flu 1819 CAS Altert 12:19 05/08/2019267.5k

pdf
Endometrial Cancer Chemo Algorithm 09:11 07/10/201812.3k

PDF
Epanutin Infatabs PIL 12:19 05/08/201953.2k

pdf
Epanutin PIL and SPC 16:47 06/06/2019301.5k

pdf
Erectile Dysfunction Pathway Nov 11 DHUFT 09:11 07/10/2018131.3k

pdf
Etrasimod for UC Commissioning Statement March 24 12:43 04/10/2024133.9k

pdf
Evra Guideline to Support Prescribing Jan 15 09:11 07/10/2018516.9k

pdf
Eye Drop Dispensers Guidance 09:11 07/10/2018190.8k

pdf
Eye Drop Conversion Table 09:11 07/10/2018245.5k

pdf
FAQ Palliative Care V1 300420 16:11 01/21/2021280.1k

pdf
FWG 2022 CS (NICE TA283) Ranibizumab Macular Oedema RVO 16:36 12/22/2022120.6k

pdf
FWG 2022 CS (NICE TA298) Ranibizumab Choroidal Neovascularization 12:23 12/23/2022118k

pdf
FWG 2022 CS (NICE TA305) Aflibercept for Visual Impairment Sec to CRVO 11:03 12/23/202297.1k

pdf
FWG 2022 CS (NICE TA346) Aflibercept in Diabetic Macular Oedema 11:10 12/23/2022149.4k

pdf
FWG 2022 CS (NICE TA460) Adalimumab and Dexamethasone Implant Non Infectious Uveitis 10:48 12/23/2022186.3k

pdf
FWG 2022 CS (NICE TA486) Aflibercept for Choroidal Neovascularisation 10:51 12/23/202295.6k

pdf
FWG 2022 CS Botulinum A Xeomin 12:04 12/23/2022147.6k

pdf
FWG 2022 CS Ocriplasmin 12:18 12/23/2022120.2k

pdf
FWG CS Lusutombopag in Thrombocytopenia in Liver Disease 16:28 12/22/2022116.8k

pdf
Falls Poster V1 13:36 09/02/2019170.5k

pdf
Faricimab for DMO Commissioning Statement NICE TA 799 10:01 08/18/2022180.6k

pdf
Faricimab for Wet AMD Commissioning Statement NICE TA800 10:01 08/18/2022182.5k

pdf
Feb19 Anti Microbial Product Infortion for the Treatment of Infectedcritically Colonised Wounds 13:40 02/20/2019139.3k

pdf
Feb 19v2 Pan Dorset Wound Care 13:32 02/20/2019229.6k

pdf
Feb 2023 KTTT 09:31 03/02/2023186.4k

docx
Feedback Form Updated V2 12:24 03/16/202331.6k

pdf
Fentanyl IR Commissioning Statement 2023 15:57 12/19/2023209.3k

pdf
Final AAI QAs for Pharmacies and Dispensing Practices 16 10 2018 12:15 10/19/2018676.9k

pdf
Final Formulary Schematic Diagram Sep18 15:14 01/02/2019367.8k

pdf
Final Guidelines for the Prescribing of Stoma Additional Products in Primary Care January 2020 14:22 02/28/2020619.7k

pdf
Final with Signature Epanutin to Dilantin DHCP Letter 05 06 19 (1) 16:47 06/06/2019158.6k

pdf
Flex 2006 09:11 07/10/2018214.2k

docx
FluOOS Claim NHSnolist V3 09:22 10/12/201840.9k

docx
FluOOS Claim NHSnolist V3 (1) 16:27 10/02/201940.9k

docx
FluOOS Claim NHSnolist V3 (3) 18:03 10/06/202143k

docx
FluOOS Community P'cy Claim NHS D V3 Review Aug 24 14:14 08/15/202323.2k

doc
FluOOS Invoice Claim V (3) 18:03 10/06/202136k

doc
FluOOS Invoice Claim V2 09:22 10/12/201836k

doc
FluOOS Invoice Claim V2 (1) 16:27 10/02/201936k

docx
FluOOS Invoice Template NHS Dorset ICS V 2 Aug23 14:14 08/15/202320.5k

docx
FluOOS PSD 09:22 10/12/201841.1k

docx
FluOOS PSD (1) 16:28 10/02/201941.5k

docx
FluOOS PSD (2) 12:59 08/24/202042.8k

docx
FluOOS PSD (3) 18:03 10/06/202143k

docx
FluOOS PSD Proforma V3 Aug 23 14:14 08/15/202322.9k

pdf
FluOOS Protocol 18-19 09:22 10/12/2018561.5k

docx
FluOOS Protocol NHS Dorset V3 Aug 23 16:02 08/15/202370.8k

pdf
FluOOS Protocol V5 19-20 16:28 10/02/2019563.5k

pdf
FluOOS Protocol V5 20-21 12:59 08/24/2020254.1k

pdf
FluOOS Protocol V5 21-22 18:03 10/06/2021241.2k

pdf
Focus on Preconception Care for Women with Epilepsy 09:11 07/10/2018317.8k

pdf
Formulary Appendix 8 Community Pharmacy Palliative Care Drugs List April 2020 21:08 04/26/2021132.3k

pdf
Formulary Continence Desmopressin (1) 12:40 06/01/2022187.7k

pdf
Formulary Guidelines for the Prescribing of Stoma Additional Products in PC Oct 21 10:52 04/29/2022291.7k

docx
Formulary Proposal Form Jan 23 14:47 08/17/2023112.4k

pdf
Formulary Schematic Diagram Nov 21 09:26 12/16/2021106.1k

pdf
Formulary Decision Making Criteria 17:23 08/31/2021106.5k

pdf
Fortacin Comissioning Statement March 17 09:11 07/10/2018343.5k

pdf
Fremanezumab for Migraine TA764 Commissioning Statement 15:18 05/09/2022125.3k

docx
GF Changes Leaflet for Patients Approved 12:06 12/21/201864.3k

pdf
GF Changes Leaflet for Patients Approved 12:12 12/21/2018382.3k

pdf
GUIDANCE ON PRESCRIBING OF CONTRACEPTIVES TO GIRLS UNDER 16 YEARS 16:04 10/15/2020358k

pdf
GUIDELINES FOR THE PHARMACOLOGICAL MANAGEMENT OF DIABETIC NEUROPATHIC PAIN IN PRIMARY CARE 09:11 07/10/2018151.2k

docx
Gastroenterology Mesalazine Asacol to Octasa Patient Switch Letter 16:18 12/14/202023.9k

pdf
Great Green Respiratory Care Poster 13:36 04/03/2023110.4k

pdf
Guidance for the Management of Insomnia and Daridorexant V2 16:56 01/23/2024151.4k

pdf
Guidance on the Use of Antipsychotics for Conditions Other than Schizophrenia 09:11 07/10/201836.2k

pdf
Guideline for Eflornithine 2023 16:50 12/15/2023147.1k

pdf
Guideline for Paracetamol Use RBCH 09:11 07/10/201869.4k

pdf
Guidelines for the Prescribing of Stoma Additional Products in Primary Care Final 09:11 07/10/2018294.1k

pdf
Guidelines for the Prescribing of Stoma Additional Products in Primary Care May 18 Approved 09:11 07/10/2018625.1k

pdf
Guidelines for the Prescribing of Stoma Additional Products in Primary Care Updated SEP 20 09:11 10/01/2020296.1k

pdf
Gynae Cancer Standard Regimens 09:11 07/10/201825.9k

pdf
HSC Impotence SLS 09:11 07/10/2018280.8k

pdf
Haematology Standard Regimens 09:11 07/10/201896.3k

pdf
H and N Palliative Chemo Algorithm 09:11 07/10/201812.6k

pdf
H and N Cancer Standard Regimens 09:11 07/10/201820.2k

pdf
H and N Chemoradiotherapy Chemo Algorithm 09:11 07/10/201816.4k

pdf
How to Make the Most of Your Meals 09:11 07/10/2018147.9k

docx
How to Upload a Document to the Dorset Formulary 18102021 V1 12:43 10/18/202111.7k

pdf
How to Upload a Document to the Dorset Formulary 18102021 V1 12:43 10/18/202131.2k

pdf
IBD High Cost Drugs Pathway V5 April 24 12:43 04/10/2024303.4k

pdf
IBD High Cost Drugs Pathway V3 Including Ozanimod and Upadacitinib Feb 23 MT May 23 15:12 05/03/2023551k

pdf
ICD AssessmentTool 09:11 07/10/2018109.1k

pdf
ICD AssessmentTool (002) 09:59 10/12/2018109.1k

pdf
IL 6 Inhibitors for Patients Hospitalised Due to COVID 19 Nov 22 13:52 11/30/2022248.4k

pdf
IN 227 Dementia Pathway 2022 V2 (002) 14:54 12/21/2022168.1k

pdf
INCLISIRAN FAQ Final Version 05 05 2023 15:44 05/10/2023109.3k

pdf
Immunosuppressant Prescribing Information Update Jan 2015 09:11 07/10/2018190.5k

pdf
In Focus Fibrates July 23 15:15 09/15/2023164.2k

pdf
In Focus Quetiapine XL Final 09:21 07/19/2018213.8k

pdf
In Focus Quinine V3 July 23 15:14 09/15/2023164.8k

pdf
In Focus PERT Jan 24 (1) 14:14 02/26/2024157.2k

pdf
Ixekizumab Commissioning Statement for TA442 09:11 07/10/2018369.8k

docx
JWFG Nonformulary Rationale Form V2 16:25 03/16/202332.3k

pdf
JWFWFG Appendix 1 Pan Dorset Wound Care Formulary 16:42 12/14/202073.1k

pdf
JWFWFG Appendix 1 Pan Dorset Wound Care Formulary (1) 16:24 12/16/202073.6k

docx
JWFWG Appendix 2 Skin Barrier Wound Care Product Request V6 16:37 12/14/202038.8k

docx
JWFWG Appendix 2 Skin Barrier Wound Care Product Request V6 (1) 16:24 12/16/202039.1k

pdf
JWFWG Dorset Skin Tear Pathway Updated February 2024 12:59 03/14/2024381.7k

pdf
JWFWG Napkin Associated Dermatitis 15:57 05/09/2022470k

pdf
JWFWG Pan Dorset Moisture Pathway 14:30 05/06/2022250.6k

pdf
Jan 2019 KTTT 10:43 01/28/2019454.2k

pdf
LFPSE Comms 03 03 23 09:09 03/30/202395.6k

pdf
LPC LMC MDS Guidance 2018 08:46 08/23/2018493.1k

pdf
Leg Cramps Leaflet Sept 23 12:10 09/27/2023199.2k

docx
Letter for Non Formulary Drugs 13:21 09/03/202014.4k

PDF
Letter of Temporary Cessation of Epanutin Oral Suspension FINAL (002) 13:44 10/23/201859.9k

docx
Letter to Hospital to Decline Prescribing Jan2017 NHSD 16:03 02/01/202341.8k

docx
Letter to Hospital to Decline Prescribing May 2023 14:58 05/18/202336.1k

pdf
Local Guidance for the Safe Use of SGLT2s Updated July 2018 14:52 10/04/2018321.6k

pdf
Local Guidance for the Safe Use of SGLT2s Updated July 2018 (1) 09:36 10/19/2018321.6k

pdf
Lung Cancer Standard Regimens 09:11 07/10/201839.6k

pdf
MIG Statement on Oral Anti Emetics 09:11 07/10/2018421.6k

pdf
MSN 2023 068 Atomoxetine 40mg and 60mg Capsules 14:18 08/11/2023145.3k

pdf
Management of Fibromyalgia 2017 09:11 07/10/2018721.8k

pdf
Management of Neuropathic Pain Final Aug 09 09:11 07/10/201829.4k

pdf
Management of Type 2 Diabetes Version 1 2 16 Apr2024 15:23 04/17/20241M

pdf
Management of Hyperhidrosis Guidance June 18 09:11 07/10/2018607k

pdf
Management of Hyperhidrosis Guidance Nov 23 15:40 12/19/2023279.3k

pdf
Management of Hypomagnesaemia in Primary Care 09:11 07/10/2018440k

pdf
Management of Hypomagnesaemia in Primary Care (1) 12:04 10/12/2020197.9k

pdf
Management of Hypomagnesaemia in Primary Care Jan 23 Copy 14:09 02/17/2023185.9k

docx
Managing Vitamin B12 Injections During COVID (002) 09:20 03/31/202041.7k

pdf
March 2023 KTTT 15:10 03/29/2023288.4k

pdf
Medical Management of Glucocorticoid Induced Osteoporosis 2012 09:11 07/10/2018252.3k

pdf
Medical Management of Glucocorticoid Induced Osteoporosis March 2020 14:58 07/13/2020218.9k

pdf
Medical Management of Glucocorticoid Induced Osteoporosis March 2020 (1) 13:02 06/03/2021219.6k

pdf
Medicine Supply Notification Salbutamol 2 5mg in 2 5ml Nebuliser Liquid Unit Dose Vials 06032024 14:14 03/07/2024141.1k

pdf
Meds Shortage Guidance Jun18 09:56 12/07/201883.5k

pdf
Memory Gateway Pathway 09:11 07/10/2018332.7k

pdf
Mental Health Discontinuation of Fluphenazine Decanoate 09:36 10/19/2018379.4k

docx
Mental Health Managing Trimipramine 09:11 07/10/201821.3k

docx
Mental Health Managing Trimipramine Final March 21 10:33 06/10/202152.3k

pdf
Mental Health Shared Care AChEI Update Nov 2018 14:24 12/28/2018670.3k

pdf
Mental Health Primary Care Protocols Depression Final 2018 09:11 07/10/2018255.1k

pdf
Mental Health Primary Care Protocols Anxiety FINAL 2018 09:11 07/10/2018177.1k

pdf
Mental Health Shared Care ADHD Adult 2018 14:24 12/28/2018594.6k

pdf
Mesothelioma 09:11 07/10/201815.2k

pdf
Methotrexate Interaction Poster 2019 11:51 12/06/2019640k

pdf
Microgynon HCP 12:31 05/24/2019154.4k

pdf
Microgynon Ovranette Comms May 2019 12:32 05/24/2019125.6k

pdf
NEW Commissioning Statement Ticagrelor 2017 09:11 07/10/2018319.5k

pdf
NHS DORSET CLINICAL COMMISSIONING GROUP POSITION STATEMENT ON ORAL ANTICOAGULANTS IN ATRIAL FIBRILLATION 09:11 07/10/2018603.7k

pdf
NHS Dorset Advice for Pc and Adhd Prescribing Following Private Diagnosis Dec 23 14:17 12/14/2023200.6k

pdf
NICE Biologics Pathway for Psoriatic Arthritis March 22 16:07 05/09/202291.6k

pdf
NICE Commissioning Statement Guselkumab PsA with Psoriasis 2021 17:20 08/31/2021126k

pdf
NICE TA 265 Denosumab 09:11 07/10/2018233.2k

pdf
NICE TA 266 Mannitol 09:11 07/10/2018403.7k

pdf
NICE TA 276 Colistimethate Sodium and Tobramycin Dry Powders 09:11 07/10/2018277.3k

pdf
NICE TA 358 Tolvaptan Commissioning Statement 09:11 07/10/2018219.1k

pdf
NICE TA 358 Tolvaptan Commissioning Statement Reviewed July 21 16:09 10/12/2021115.5k

pdf
NICE TA 383 TNF Alpha Inhibitors for AS and Non Radiographic Axial Spondyloarthritis Commissioning Statement 09:11 07/10/2018343.4k

pdf
NICE TA 803 CS Risankizumab for Psoriatic Arthritis 12:49 10/18/2022131.8k

pdf
NICE TA 805 CS Icosapent Ethyl 09:43 10/12/2022164.8k

pdf
NICE TA 807 CS Roxadustat for Treating Symptomatic Anaemia in Chronic Kidney Disease 09:43 10/12/2022119k

pdf
NICE TA 814 CS for Biologics in Dermatitis 10:21 11/07/2022152.3k

pdf
NICE TA 815 CS Guselkumab for Psoriatic Arthritis 13:40 10/19/2022129.3k

pdf
NICE TA 820 CS Brolucizumab for Treating Diabetic Macular Oedema 11:32 10/17/2022237.3k

pdf
NICE TA Commissioning Statement Andexanet May 2021 10:48 07/27/2021139.5k

pdf
NICE Upadacitinib for Active Psoriatic Arthritis NICE TA768 Commissioning Statement 15:22 05/09/2022133.5k

pdf
NICE Commissioning Statement Budesonide for Eosinophilic Oesophagitis 2021 15:28 08/24/2021145.3k

doc
NMP Change of Circ Sept18 08:59 12/14/2021133k

pdf
NOACs in a Nutshell 09:11 07/10/2018225.3k

pdf
NOTIFICATION OF HIGH COST EXCLUDED DRUGS June 2016 09:23 07/19/2018199.4k

doc
NOTIFICATION OF HIGH COST EXCLUDED Drugs 2018 09:30 07/19/201841k

pdf
NSAID Info Prescribers 0519 09:14 05/16/2019651.3k

pdf
NSCLC CRT 09:11 07/10/201810.5k

pdf
NSCLC Palliative 09:11 07/10/201819.7k

pdf
Nalmefene COMMISSIONING STATEMENT Jan 2015 09:11 07/10/2018339.4k

pdf
National Hydroxycarbamide Shared Care Protocol DMAG Approved Jan 23 12:30 02/17/2023345.3k

pdf
Nebuliser Pathway Pdf V2 May 23 14:21 08/23/2023377.4k

pdf
Nifedipine Memo 13 Feb 2019 (1) 12:52 02/18/201993.1k

pdf
Non Formulary Rationale Form2 2019 15:27 01/31/201913.2k

pdf
NonFormulary Rational Form2 Edit 16:48 05/30/201952.7k

pdf
ONS QA April 2021 14:09 10/14/2021149.4k

pdf
OTC GP Practice Letter 09:17 03/25/2019265.5k

pdf
Ocriplasmin Comissioning Statement 09:11 07/10/2018283.9k

pdf
Oct 2018 KTTT 15:01 11/01/2018457.1k

pdf
Oesophageal Cancers 09:11 07/10/201814.1k

pdf
Oesophagogastric 09:11 07/10/201815.6k

pdf
Omalizumab Commissioning Statement NICE TA 339 Updated 2018 09:36 10/19/2018531.2k

pdf
Opioid Substitute COMMISSIONING STATEMENT 09:11 07/10/2018358.1k

pdf
Osteoporosis Commissioning Statement Bisphosphonates TA464 May 2021 16:11 08/23/2021207.3k

pdf
Osteoporosis Denosumab Guideline Nov 21 09:38 12/10/2021204.7k

pdf
Osteoporosis Denosumab Guideline Nov 21 (1) 11:06 01/27/2023204.7k

pdf
Osteoporosis Fracture Management Pathway from Nishan De Fonseka DME Consultant POOLE (003) 16:21 08/23/2021205.2k

pdf
Osteoporosis Guidance 13:03 10/26/2018447.9k

pdf
Ovarian Cancer Chemo Algorithm 09:11 07/10/201816.6k

pdf
PALIPERIDONE LONG ACTING INJECTION Guidelines 2013 09:11 07/10/2018237.1k

pdf
PATHWAY FOR PRESCRIBING ORAL NUTRITIONAL SUPPLEMENTS IN DORSET CCG A4 09:11 07/10/2018507k

pdf
PATHWAY FOR PRESCRIBING ORAL NUTRITIONAL SUPPLEMENTS IN DORSET CCG A4 Updated MUST Link 161221 18:28 12/16/2021198.8k

pdf
PATHWAY FOR PRESCRIBING ORAL NUTRITIONAL SUPPLEMENTS IN DORSET CCG April 2021 11:30 09/05/2021198k

pdf
PATHWAY FOR PRESCRIBING ORAL NUTRITIONAL SUPPLEMENTS IN DORSET ICB APRIL 23 (1) 10:49 12/07/2023250.3k

pdf
PCDS GLP 1 RA Shortage Statement 1 16:22 10/12/202296.1k

pdf
PHE Guidance for Phased Re Introduction of Hepatitis B Vaccine for Lower Priority Groups 2018 09:11 07/10/2018247k

pdf
PMC Flyer Subscribers 15:49 05/02/2019124.5k

pdf
PRN00058 Group a Streptococcus in Children Interim Clinical Guidance December 2022 09:49 12/12/2022267.3k

pdf
Paediatric Liquid Medicines Standardised Concentrations Sep 20 Version 1 2 11:56 12/16/2020473.9k

pdf
Pain Management Guidance 2019 13:09 09/26/20191.8M

pdf
Palforzia for Peanut Allergy NICE TA 769 Commissioning Statement 15:27 05/09/2022130.5k

pdf
Palliative Care Drug Pharmacies Updated Feb 24 14:37 02/28/2024166.5k

pdf
Palliative Care Handbook 7thEdition Oct2010 09:11 07/10/2018384.3k

pdf
Pan Dorset Wound Care Formulary 2017 2018 FINAL 09:11 07/10/2018127k

pdf
Pan Dorset Wound Care by Tissue Type March 2023 16:12 04/18/2023113.3k

pdf
Pan Dorset Wound Care by Tissue Type Updated February 2024 12:59 03/14/2024107.1k

pdf
Pan College Guidance Document on Valproate Use V2 1 09:46 04/28/20221.4M

pdf
PancreaticEnzymeReplacementTherapy (A Guide to Taking) 12:04 10/12/20201k

pdf
PancreaticEnzymeReplacementTherapy (A Guide to Taking) (1) 12:26 10/12/202050.5k

pdf
Pancreatic Cancer 09:11 07/10/201815.1k

pdf
Parkinson's Disease Guideline Nov 20 15:09 12/14/2020314k

pdf
Pathway for Taking a Drug through the Formulary Process 17:23 08/31/202160.2k

pdf
Patient Information DiamorphineFINAL 09:25 08/14/2018255k

pdf
Patient Leaflet Freestyle May 2018 13:14 07/27/2018327k

pdf
Patiromer Commissioning Statement March 2020 13:53 04/30/2020158.4k

pdf
Pevanti Prednisolone Commissioning Statement May 15 09:11 07/10/2018212.2k

pdf
Pevanti Commissioning Statement Updated July 2020 14:50 09/23/2020118k

pdf
Pharmacological Intervention in ADHD Prescribing Algorithm 09:11 07/10/201827.2k

pdf
Pharmacological Management of Parkinsons Disease 2010 09:11 07/10/201831.4k

pdf
Phosphate Binder Shared Care Guideline Final Aug 2020 12:04 10/12/2020221.5k

pdf
Plenadren Comissioning Statement Updated July 2020 10:23 08/19/2020190k

pdf
Plenadren Comissioning Statement Updated May 2017 09:11 07/10/2018511.2k

pdf
Policy and Pathway for Management of Hyperhidrosis 09:11 07/10/2018413.5k

pdf
Policy for Primary and Secondary Management of Osteoporosis March 2020 14:58 07/13/2020228.1k

pdf
Position Statement on the Prescribing of Preservative Free Eye Drops 09:11 07/10/2018198.4k

pdf
Potassium Citrate Stopping Criteria Letter 14:37 12/21/202292.1k

pdf
Pregabalin PSL April 2022 V2 12:23 11/01/2022168.3k

pdf
Pregabalin Statement Mar15 NHSE 09:11 07/10/201875.8k

pdf
Prescribable CGM CS 8 March 2023 Post DMAG (003) 11:49 05/18/2023166.9k

pdf
Prescribable CGM CS Sept 2023 09:50 10/23/2023144.2k

pdf
Prescribable CGM Commissioning Statement FINAL Dec 2022 10:35 12/21/2022168.5k

pdf
Prescribing of Quetiapine MR and IR Formulations 09:11 07/10/2018163.7k

pdf
Primary Care DVT Pathway NOAC 09:11 07/10/2018580.8k

pdf
Primary Care Management of High INR July 2017 09:11 07/10/2018637.5k

pdf
Private Prescribing in Primary Care 13:14 07/27/2018431.4k

pdf
Private Prescribing in Primary Care (1) 13:01 06/01/2022172.1k

pdf
Private Prescribing in Primary Care NHSD 16:03 02/01/2023166.5k

pdf
Prostate Cancer Chemo Algorithm 09:11 07/10/201813k

pdf
Proton Pump Inhibitor Deprescribing Algorithm (adults) PrescQIPP V2 September 2020 12:04 10/12/2020119.4k

pdf
Prucalopride Commissioning Statement March 2017 09:11 07/10/2018251.1k

pdf
Psoriasis Management May 19 12:28 08/02/2019641.4k

pdf
Psoriasis Management May 2018 09:11 07/10/2018794.9k

pdf
Psoriasis Management Sept 19 13:05 09/19/2019643.2k

pdf
Psoriasis Management Sept 19 (1) 09:58 10/17/2019643.2k

pdf
Psoriasis Management in Adults 2023 16:24 12/15/2023465.6k

pdf
Psoriasis Management in Adults April 21 13:14 08/23/2021350.9k

pdf
Psoriasis Management 2017 09:11 07/10/2018489.6k

pdf
Psoriasis Management in Adults March 17 09:11 07/10/2018482.8k

pdf
QTc Prolongation Guidance for Mental Health Prescribers 09:23 09/05/2019397.3k

pdf
Quick Formulary Guide Document (1) 11:11 06/30/2022103.4k

pdf
Quick Formulary Guide Document Aug 23 15:06 08/02/2023132k

pdf
RA Biologics Pathway July 2017 09:11 07/10/2018361.5k

pdf
RA Pathway for NICE TAs Jan 2018 09:11 07/10/2018368.6k

pdf
RBCH Methotrexate Policy 062019 16:32 09/17/2019712.2k

pdf
RMOC Combination Use of Biologics for Different Co Morbidities RMOC Regional Advisory Statement V1 July21 10:55 12/17/2021140.4k

pdf
Recording Medication Issued at Another Organisation 062021 15:28 07/08/2021285.8k

pdf
Reminder About Paediatric Amoxicillin Doses 09:11 07/10/2018207.8k

pdf
Renal Cell Cancer Chemo Algorithm 09:11 07/10/201823.8k

pdf
Revised INTERIM PROTOCOL ON DISPENSING OF ADRENALINE AUTOINJECTORS, 150microgram Applying from 5 November 2018 until Further Notification 09:26 11/13/2018257.5k

pdf
Revised Parkinsons Disease Guideline May 18 09:11 07/10/2018538.6k

pdf
Revised Version July Policy for Primary and Secondary Management of Osteporosis July Amended 2020 09:35 07/23/2020246.3k

pdf
Rheum CS Ixekizumab TA537 Psoriatic Arthritis After DMARDs 16:21 12/22/2022164.5k

pdf
Rheumatology Dorset Biologic RA Pathway V2 Dec 2021 10:27 12/17/2021132.8k

pdf
Rheumatology Dorset Biologic RA Pathway V2 July 2021 13:10 08/25/2021129.7k

pdf
Risks Associated with Gabapentinoids V2 March 2023 16:31 04/18/2023204.3k

pdf
Rosacea Pathway Nov 23 16:12 12/15/2023213k

pdf
Rosacea Pathway November 2015 09:11 07/10/2018404.1k

pdf
Rosacea Pathway December 2018 09:54 02/27/2019449.9k

pdf
SCG Fiasp 15:45 12/28/2018408.9k

docx
SCG for Prescribing Dronedarone (Multaq) for the Treatment of Non Permanent AF July 2021 14:28 08/20/202151k

pdf
SCLC Extensive Disease 09:11 07/10/201811.9k

pdf
SCLC Limited Disease 09:11 07/10/201812.4k

pdf
SDA 2019 001 Epanutin 30mg in 5ml 16:47 06/06/201999.8k

pdf
SGLT2s Commissioning Statement July 2019 08:00 09/23/2019655.3k

pdf
SGLT2s Commissioning Statement July 2021 12:07 08/23/2021174k

pdf
SHARED CARE GUIDELINE FOR PRESCRIBING RIFAXIMIN (TARGAXAN®) 12:04 10/12/2020213.8k

pdf
SHD Pathway 37 Non Acute Pelvic Pain in Women 09:32 09/23/20191.3M

pdf
SMS Nov 22 19:18 11/30/2022234.9k

pdf
SSC1620 GD Prescribing 09:11 07/10/2018327.4k

pdf
SSC2338 NICE Guidance Inclisiran TA733 Update Letter 030221 (1) 10:48 02/28/2022128.7k

pdf
SSC 2502 Changes to Patient Cohorts Eligible for COVID 19 Treatments 11:54 04/26/2023124.4k

docx
SWASFTPatientInformationFormforGPSurgeries 09:11 07/10/2018841.7k

pdf
Safety Bulletin Dosulepin Final 2021 10:33 06/10/2021267.8k

pdf
Safety Pen Needles for DNs 10:59 04/23/2019382.4k

pdf
Sarcoma Standard Regimens Adopted from London 09:11 07/10/2018117.3k

pdf
Sativex Pathway Dorset Nov 20 14:51 12/14/2020163.8k

pdf
Schematic Diagram for DMAG April 18 09:11 07/10/2018343k

pdf
Shared Care Guideline for Colistimethate in Non CF Bronchiectasis Nov 2020 15:35 05/10/2021157.4k

pdf
Shared Care Nadolol January 2019 14:00 02/28/2019163k

pdf
Shared Care Sativex November 2020 14:51 12/14/2020238.2k

pdf
Shared Care Tiagabine Feb19 14:45 08/08/2019538.4k

doc
Shared Care Template Final Nov 2018 09:21 01/28/2019151.5k

pdf
Shared Decision Tool CGM V 1 20 12 2022 10:31 12/21/2022125.4k

pdf
Shared Decision Tool CGM V 2 1 29 3 2023 11:49 05/18/2023125.6k

doc
Shortage Memo Hydrocortisone Solution for Inj FINAL 2 09:11 07/10/2018113k

pdf
Shortage Memo Levomepromazine FINAL 09:26 04/12/2019229k

doc
Shortage Memo Metoprolol Final 09:50 02/25/201986k

pdf
Shortage Memo Strontium VS June 19 2017 09:11 07/10/2018170.8k

pdf
Shortage Memo Terbutaline Bricanyl Turbohaler Nov2018 Final 11:55 11/30/2018234k

pdf
Sick Day Rules for People with Type 2 Diabetes V1 (1) 15:24 08/30/2023167.4k

docx
Skin Barrier Wound Care Product Request 10 07 19 09:41 07/30/201934.5k

docx
Skin Barrier and Wound Care Product Request 09:11 07/10/201830.2k

pdf
Soap Substitutes Patient Information Leaflet Nov 23 15:46 12/15/2023109k

pdf
Solriamfetol for Excessive Daytime Sleepiness TA758 Commissioning Statement 15:51 05/09/2022163k

pdf
Somatropin Commissioning Statement Jan 17 09:11 07/10/2018408.9k

pdf
South ALS Flyer May 2023 09:19 03/30/2023376.2k

pdf
Squamous Oesophageal Cancers 09:11 07/10/20188.8k

pdf
Standard Regimens for Colorectal Cancer 09:11 07/10/201833.4k

pdf
Statement for Sterile Dressing Packs May18 09:11 07/10/2018376.9k

pdf
Step by Step Guide to Using the Dorset Wound Care Products Template on SystmOne 14:48 11/12/20211.2M

pdf
Step by Step Guide to Using the Dorset Wound Care Products Template on SystmOne NHSD 16:03 02/01/2023512.1k

pdf
Sterile Dressing Pack Statement 10:23 08/19/2020147.3k

pdf
Sterile Dressing Pack Statement Final 15:00 12/22/2022147.9k

pdf
Steroid Cards In Focus June 2021 11:00 04/23/2024230.3k

pdf
Stoma In Focus Final 09:21 07/19/2018369.2k

pdf
Stoma Additional Products Savings Guidance DocxFINAL 2020 15:18 07/22/2020286.9k

pdf
Stoma Additional Products Savings Guidance DocxFINALNEW 10:52 07/20/2018715k

pdf
Stopping DOACs Before Procedures August 2018 10:45 09/11/2018371.2k

pdf
Stopping Your PPI Patient Information Leaflet 09:04 10/04/201829.9k

pdf
Stopping Your PPI Patient Information Leaflet (2) 12:48 09/16/2022202.7k

pdf
Summary of 2017 FSRH Emergency Contraception Guidelines 09:11 07/10/2018242.7k

pdf
SystmOne CGM Protocol V 1 20 12 2022 10:31 12/21/2022328.5k

pdf
SystmOne CGM Protocol V 2 29 03 2023 15:56 03/29/2023341.6k

pdf
T1DM Prescribable CGM Pathway 1 1 20 12 22 11:49 05/18/2023116.9k

pdf
T1DM Prescribable CGM Pathway 20 12 22 10:31 12/21/2022115.6k

pdf
T2DM Prescribable CGM Pathway 1 1 29 03 23 11:49 05/18/2023166.3k

pdf
T2DM Prescribable CGM Pathway Sept 2023 09:50 10/23/2023115.9k

pdf
TA329 COMMISSIONING STATEMENT 09:11 07/10/2018216k

docx
TEST WORD 13:57 03/25/20201k

pdf
Tacrolimus Prescribing Guidance Sep 2018 09:42 04/11/2019350.8k

pdf
Targeted Release Budesonide Commissioning Statement NICE TA937 March 24 16:53 03/14/2024170.5k

pdf
Test Strips Formulary Document 11:21 08/09/2018392.8k

pdf
Testosterone Guideline April 22 15:12 04/25/2022131.9k

pdf
Thickener Quantities 2020 15:16 12/14/2020168k

pdf
Tips for Taking Supplements April 2021 11:20 09/05/2021113.6k

pdf
Tips for Taking Supplements Jul 17 09:11 07/10/2018119.7k

pdf
Tirzepatide and GLP1 Prescribing in SystmOne 10:47 04/04/2024186.4k

pdf
Tirzepatide and GLP1 Prescribing in SystmOne (1) 15:23 04/17/2024186.4k

pub
To Add DOAC Alert Card DCH Sept V1 3 2016 14:08 11/11/2019123k

pdf
Trans Anal Irrigation Pathway March24 17:09 03/07/2024821.2k

pdf
Treatment of Constipation in Adults V3 Nov 2022 12:30 02/17/2023253.9k

pdf
Type 2 Diabetes in Adults SGLT2 April 23 15:24 08/30/2023141.4k

pdf
Type 2 Guidelines July 2017 09:11 07/10/2018336.4k

pdf
UHD Anticoagulation Guideline Sept2020 08:54 12/15/20201.4M

pdf
UHD Guideline for the Management of Non Massive Pulmonary Embolism Aug2020 08:54 12/15/20201M

pdf
UHD Massive PE Guideline V1 0 Nov2019 08:54 12/15/2020549k

pdf
UHD VTE Prevention Guidelines Aug2020 08:55 12/15/20202.5M

pdf
UI Formulary June 2020 Final 10:23 08/19/2020143.9k

pdf
Understanding Urine Results PH Final 11:30 05/10/2022170.6k

pdf
Understanding Urine Results PH Final NHSD 16:03 02/01/2023177.1k

pdf
Understanding Urine Sampling 09:16 03/29/2019487.4k

pdf
Updated Commissioning Statement OPEP (flutter) Devices 2019 (1) 12:34 05/30/2023212.8k

pdf
Updated Eligibility Criteria for Antivirals and NMABs 2022 06 24 15:43 06/29/2022469.6k

pdf
Upper GI Standard Regimens 09:11 07/10/2018125.3k

pdf
Urinary Incontinence Preferred Product Booklet 2020 10:41 07/08/2020629k

pdf
Urinary Incontinence Product Booklet 2019 11:25 05/24/2019645.2k

pdf
Urine Dipsticks Leaflet To Dip or Not to Dip 14:18 10/23/2018566.5k

pdf
Urology Standard Regimens 09:11 07/10/201828.3k

pdf
Urticaria Pathway 2019 V2 09:23 09/05/2019495.8k

pdf
Urticaria Pathway 2019 V2 (002) 13:01 02/27/2020495.8k

pdf
Urticaria Pathway July 16 09:11 07/10/2018307k

pdf
Urticaria Pathway Nov 2023 16:06 12/15/2023242k

pdf
Ustekinumab Commissioning Statement NICE TA633 V1 15:36 07/30/2020159.7k

pdf
V2 DB Commissioning Statement PCSK9 12:24 10/30/2019216.5k

pdf
V3 Sativex Pathway Dorset Dec 20 11:28 12/21/2020164.1k

pdf
V4 Sativex Pathway Dorset February 2021 (002) 10:22 02/03/2021165.5k

pdf
Vesomni Commissioning Statement 09:11 07/10/2018324.8k

pdf
Vit D Guidelines March 2020 14:58 07/13/2020254.8k

pdf
Vit D Guidelines V4 14:00 02/28/2019148.8k

pdf
Vitamin D Management April 2013 09:11 07/10/2018450.6k

pdf
Vitaros August 14 09:11 07/10/2018344.3k

pdf
Vit B12 Guidelines V1 3 Post DMAG Jan 20 X2 16:00 06/07/2022304.7k

pdf
Vit B12 Guidelines V1 4 2022 11:54 11/07/20221.2M

pdf
Vortioxetine Commissioning Statement NICE TA 367 09:11 07/10/2018211.6k

pdf
Vulva Vagina Cancer Chemo Algorithm 09:11 07/10/201812k

pdf
Washout Periods for Biologics (psoriasis) August 2020 14:54 09/07/2020189.1k

pdf
Wessex Palliative Care Handbook 2014 13:39 09/20/20181.1M

doc
What Dose of Vitamin D Should Be Prescribed for the Treatment of Vitamin D Deficiency 09:11 07/10/201895k

pdf
Yasmin Prescribing Guidance Sept 2007 13:10 11/23/201839.8k

pdf
Aflibercept 09:10 07/10/2018205k

pdf
Commissioning Statement Brolucizumab Wet AMD Feb 2021 10:27 03/01/2021116.9k

pdf
Commissioning Statement SGLT2s May 2019 12:52 06/25/2019108.9k

pdf
Commissioning Statement SGLT2s May 2019 (1) 10:33 07/16/2019505.7k

pdf
Commissioning Statement for NICE TA 375 RA 09:11 07/10/2018354.9k

pdf
Commissioning Statement for TA445 09:11 07/10/2018396.1k

pdf
Commissioning Statement for Ustekinumab in Active Psoriatic Arthritis 09:11 07/10/2018235.7k

pdf
Commissioning Statement for Dexamethasone in DMO 15:18 12/21/2022129.1k

pdf
Commissioning Statement for Dupilumab 13:06 08/17/2018392.9k

pdf
Commissioning Statement for Fostamatinib for Refractory ITP 15:39 12/21/2022145.4k

pdf
Commissioning Statement for Golimumab 09:11 07/10/2018501.8k

pdf
Commissioning Statement for Lubiprostone March 2018 09:11 07/10/2018546k

pdf
Commissioning Statement for Sarilumab 09:11 07/10/2018499.7k

pdf
Commissioning Statement Tildrakizumab Plaque Psoriasis June19 10:54 07/11/2019382.6k

pdf
Dapoxetine Commissioning Statement 09:11 07/10/2018219.5k

pdf
Ferric Maltol Guideline 13:30 04/05/2023247.8k

pdf
Final CS Risankizumab for Previously Treated Moderately to Severely Active Crohn's Disease Oct 23 14:12 10/05/2023114.2k

pdf
Final Commissioning Statement for Deucravacitinib for Plaque Psoriasis NICE TA 907 14:50 08/31/2023168.5k

pdf
Final Commissioning Statement for Somatrogon Feb 23 15:05 04/28/202391.8k

pdf
Final Commissioning Statement Upadacitinib for Crohns Disease June 23 14:52 08/30/2023129.3k

pdf
Final Commissioning Statement Eptinezumab March 23 15:00 04/28/2023111.6k

pdf
Final Dorset Migraine Treatment V1 6 March 23 09:56 05/23/2023153.6k

pdf
Gp HepB Vaccine Recovery Plan Signed 2018 FINAL 09:11 07/10/2018164.9k

pdf
Hyperhidrosis Pathway Jan 19 09:53 02/27/2019610.1k

pdf
Kadcyla Letter 09:11 07/10/2018257.6k

pdf
Lesinurad Commissioning Statement 09:11 07/10/2018580.6k

pdf
Management of Osteoporosis 2012 09:11 07/10/2018379.8k

pdf
Mefloquine and Diving 09:11 07/10/2018310.5k

pdf
Methotrexate Policy 09:11 07/10/2018418.1k

pdf
Mirabegron Comissioning Statement Sept 13 09:11 07/10/2018123.6k

pdf
NMABs Hospitalised RPS (2) 09:50 12/24/2021323.1k

pdf
Omeprazole Info for Prescribers PQ0519 09:13 05/16/2019144.1k

pdf
Opus Coronavirus Contingency Safe Administration of Medicines from Original Packs (3) 11:37 04/07/2020613.7k

pdf
Oral Ketamine Comissioning Statement Final May 14 09:11 07/10/2018215.6k

pdf
Outpatients Guidance 2016 11:33 12/08/2020212.8k

pdf
PNET Algorithm 09:11 07/10/20186.5k

pdf
Prescqipp Proton Pump Inhibitor Desprescribing Algorithm 09:04 10/04/201893.1k

pdf
Stoma Additional Products Savings Guidance Pdf FINAL 09:11 07/10/2018693.7k

pdf
Traffic Light Categorisations Redrafted March 2014 Final 11:00 04/23/2024423k

pdf
Ukhsa Briefing Note B Cenocepacia Final 10:43 11/23/202351.2k

pdf
Valproate Guidance March 2019 13:44 04/18/20191.3M